Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June

ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced that the Company will participate in the following upcoming investor conferences in May and June:

SVB Securities Biopharma Private Company Connect: Members of management will be available for virtual one-on-one meetings on Wednesday, May 24, 2023 and Thursday, May 25, 2023.

Stifel 2023 Tailoring Genes: Genetic Medicines Day: Benjamin Oakes, Ph.D., Chief Executive Officer of Scribe, will present a virtual corporate overview on Tuesday, May 30, 2023 at 12:05 p.m. ET.

Jefferies Healthcare Conference: Benjamin Oakes, Ph.D., Chief Executive Officer of Scribe, will present a corporate overview on Friday, June 9, 2023 at 8:00 a.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.

About Scribe Therapeutics

Scribe Therapeutics is revolutionizing the development of optimized genetic medicines that have the potential to durably treat disease at scale. Our CRISPR by Design™ approach engineers bacterial immune systems into a premier suite of genome editing tools built for unique molecular advantages in activity, specificity and deliverability that translate into safer and more effective genetic therapies. Co-founded by Nobel Prize winner Jennifer Doudna and backed by leading life sciences investors, Scribe is engineering the future of genetic medicine. To learn more, visit www.scribetx.com.

Contacts

Investor Contact:
Stern IR for Scribe Therapeutics

[email protected]

Media Contact:
Thermal for Scribe Therapeutics

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.